Pharmacokinetics of mitiperstat in participants with hepatic impairment

Trial Identifier:	D6581C00002
Sponsor:	AstraZeneca
NCTID::	NCT05751759
Start Date:	March 2023
Primary Completion Date:	August 2024
Study Completion Date:	August 2024
Condition:	Liver, Pancreas & Gallbladder - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
US, CA	Rialto, CA, US, 92377
US, TX	San Antonio, TX, US, 78215

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.